Medpace Holdings Inc. | Mid-cap | Healthcare
$326.03
1.55%
| Medpace Holdings Stock Comparison:
Medpace Holdings vs Thermo FisherMedpace Holdings vs DanaherMedpace Holdings vs Qiagen N.VMedpace Holdings vs Charles RiverMedpace Holdings vs Guardant HealthMedpace Holdings vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.1B
Gross Profit 656.3M 31.12%
Operating Income 446.9M 21.19%
Net Income 404.4M 19.17%
EPS (Diluted) $12.63

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 1.3B
Shareholders Equity 825.5M
Debt to Equity 1.54

Cash Flow Metrics

Operating Cash Flow 604.0M
Free Cash Flow 572.3M

Revenue & Profitability Trend

Medpace Holdings Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 2.1B 1.9B 1.5B 1.1B 925.9M
Cost of Goods Sold 1.5B 1.4B 1.0B 814.2M 647.2M
Gross Profit 656.3M 524.5M 432.4M 328.2M 278.7M
Operating Expenses 180.2M 161.4M 131.4M 108.4M 92.2M
Operating Income 446.9M 336.8M 278.7M 198.6M 167.0M
Pre-tax Income 475.9M 335.7M 282.9M 201.9M 168.5M
Income Tax 71.5M 52.9M 37.5M 20.0M 23.1M
Net Income 404.4M 282.8M 245.4M 181.8M 145.4M
EPS (Diluted) $12.63 $8.88 $7.28 $4.81 $3.84

Income Statement Trend

Medpace Holdings Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.0B 593.8M 334.0M 690.9M 473.7M
Non-Current Assets 1.1B 1.1B 1.0B 969.0M 917.0M
Total Assets 2.1B 1.7B 1.4B 1.7B 1.4B
Liabilities
Current Liabilities 1.1B 925.1M 803.5M 557.2M 440.1M
Non-Current Liabilities 170.8M 172.7M 162.6M 149.8M 144.8M
Total Liabilities 1.3B 1.1B 966.1M 707.0M 584.9M
Equity
Total Shareholders Equity 825.5M 559.0M 386.4M 952.9M 805.8M

Balance Sheet Composition

Medpace Holdings Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 404.4M 282.8M 245.4M 181.8M 145.4M
Operating Cash Flow 604.0M 348.3M 345.7M 246.3M 238.2M
Investing Activities
Capital Expenditures -36.5M -36.6M -36.9M -28.3M -31.3M
Investing Cash Flow -28.3M -34.6M -38.7M -31.4M -31.2M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -169.9M -349.0M -1.1B -62.1M -98.3M
Free Cash Flow 572.3M 396.7M 351.2M 235.1M 227.3M

Cash Flow Trend

Medpace Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.58
Forward P/E 24.71
Price to Book 15.48
Price to Sales 4.11
PEG Ratio 24.71

Profitability Ratios

Profit Margin 19.31%
Operating Margin 20.32%
Return on Equity 65.83%
Return on Assets 15.45%

Financial Health

Current Ratio 0.73
Debt to Equity 25.33
Beta 1.48

Per Share Data

EPS (TTM) $13.09
Book Value per Share $19.94
Revenue per Share $69.92

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
medp 8.9B 23.58 15.48 65.83% 19.31% 25.33
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Qiagen N.V 10.1B 108.63 2.97 2.67% 4.68% 41.36
Charles River 7.2B 681.33 2.27 -0.67% -0.49% 92.21
Guardant Health 6.0B -14.19 -24.95 312.48% -53.82% -5.21

Financial data is updated regularly. All figures are in the company's reporting currency.